News

Dispensed Daily: Developing a coronavirus drug based on patients’ blood — COVID-19’s effects on the nervous system — Economic assistance programs are ending

Hello, Welcome to Dispensed Daily, your daily dose of healthcare news from Business Insider. If we haven’t met yet, my name’s Lydia Ramsey Pflanzer, and I’m a healthcare editor here at Business Insider. I typically write our weekly healthcare newsletter,Dispensed. We’re testing out a new daily format for our BI […]
Dispensed Daily: Developing a coronavirus drug based on patients’ blood — COVID-19’s effects on the nervous system — Economic assistance programs are ending
Markets

Takeda’s considering turning up the heat on its bid for Shire

Takeda is considering a new bid for Adderall drugmaker Shire, raising the share price to 47 British pounds (about $US66) per share up from 46.50 per share (about $US65), Bloomberg reported Friday. Shire has already turned down three offers from the Japanese pharmaceutical company, the last of which was a […]
Takeda’s considering turning up the heat on its bid for Shire
Markets

A bidding war for the maker of Adderall stalled out after just 4 hours

Shire rejected Takeda‘s $US60 billion takeover bid on Thursday morning. Allergan then confirmed it was “in the early stages of considering a possible offer” for Shire, potentially creating a bidding war for the $US50 billion drugmaker. That sent Allergan’s stock price spiraling, down more than 8%. Allergan said Thursday afternoon […]
A bidding war for the maker of Adderall stalled out after just 4 hours